目前对胸膜上皮瘤的治疗方法
Alfredo Tartarone1, Rosa Lerose2, Alessandro Rocco Lettini3
1Department of Onco-Hematology, Division of Medical Oncology, IRCCS-CROB Referral Cancer Center of Basilicata, 85028 Rionero in Vulture, Italy.
Life (Basel, Switzerland)
|May 27, 2023
概括
胸膜上皮瘤 (TETs) 很少见,但最常见的是前端中瘤. 管理涉及手术,各种疗法,以及个性化患者护理的多学科方法.
科学领域:
- 在瘤学瘤学.
- 胸部外科手术 胸部外科手术
背景情况:
- 胸膜上皮瘤 (TETs) 包括胸膜瘤,胸膜癌和神经内分泌瘤.
- 这些罕见的瘤起源于胸膜上皮细胞.
- TETs是最常见的瘤类型,在前半中发现.
研究的目的:
- 提供当前对胸膜上皮瘤的理解和管理的概述.
- 突出多学科方法在治疗这些不常见的恶性瘤的重要性.
主要方法:
- 审查目前对TETs的治疗策略.
- 讨论治疗方法,包括手术,化疗,放射治疗和化疗-放射治疗.
- 强调基于的化疗在晚期或转移性疾病中的作用.
主要成果:
- 晚期/转移性TET的标准治疗包括基于的化疗.
- 新药物和组合正在研究以提高疗效.
- 通过多学科团队提供个性化的护理对于最佳的患者结果至关重要.
结论:
- 有效管理TET需要一个全面的,个性化的战略.
- 目前正在进行的研究旨在完善治疗方案,以改善患者的预后.
- 一个协作式的团队方法确保为每个患有胸膜上皮瘤的患者提供量身定制的护理.
相关概念视频
01:27Tumor Immunotherapy
577
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
577
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
02:49Cancer Therapies
7.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.8K